Formulation and Evaluation of Limonene-Based Membrane-Moderated Transdermal Therapeutic System of Nimodipine

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 1, 2004, Pages 1-9

  Krishnaiah, Y S R ^a   Bhaskar, P ^a   Satyanarayana, V ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Formulation; Limonene; Nimodipine; TTS

Indexed keywords

ADHESIVE AGENT; COPOLYMER; ETHYLENE VINYL ACETATE COPOLYMER; EVA 2825; HYDROXYPROPYLMETHYLCELLULOSE; LIMONENE; NIMODIPINE; PENETRATION ENHANCING AGENT; VINYL ACETATE;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MEMBRANE PERMEABILITY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SKIN PERMEABILITY; STEADY STATE; VOLUNTEER;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANIMALS; BIOLOGICAL AVAILABILITY; CELL MEMBRANE PERMEABILITY; CHEMISTRY, PHARMACEUTICAL; CYCLOHEXENES; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; EXCIPIENTS; GELS; HUMANS; MALE; METHYLCELLULOSE; NIMODIPINE; POLYVINYLS; RATS; SKIN ABSORPTION; TERPENES; TISSUE ADHESIVES; VINYL COMPOUNDS;

EID: 1442276265     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490280372     Document Type: Article

References (29)

1. Diez, I., Colom, H., Moreno, J., Obach, R., and Peraire, C. 1991. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 80:931-934.
2. El-Kattan, A. F., Asbill, C. S., and Michniak, B. B. 2000. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 198:179-189.
3. El-Kattan, A. F., Asbill, C. S., Kim, N., and Michniak, B. B. 2001. The effect of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 215:229-240.
4. Gabiga, H., Cal, K., and Janicki, S. 2000. Effect of penetration enhancers on isosorbide dinitrite penetration through rat skin from a transdermal therapeutic system. Int. J. Pharm. 199:1-6.
5. Ghosh, T. K., Adir, J., Xiang, S. L., and Onyilofur, S. 1995. Transdermal delivery of metoprolol II: In vitro skin permeation and bioavailability in hairless rats. J. Pharm. Sci. 84:158-160.
6. Hayton, W. L., and Chen, T. 1982. Correction of perfusate concentration samples removal. J. Pharm. Sci. 71:820-821.
7. Ho, H. O., Chen, L. C., Lin, H. M., and Sheu, M. T. 1998. Penetration enhancement by limonene combined with a solubulization effect in a solvent system. J. Control. Rel. 51:301-311.
8. Hunt, J. N. 1951. Gastric emptying and secretion in man. Physiol. Rev. 39:491.
9. Hunt, J. N., and Spurgel, W. R. 1951. Pattern of emptying of the human stomach. J. Pysiol. 113:157.
10. Jain, S. K., Vyas, S. P., and Dixit, V. K. 199. Effective and controlled transdermal delivery of ephedrine. J. Control Release. 12:257-263.
11. Julraht, K., Keith, A. P., and James, A. W. 1995. Development of a transdermal delivery device for melotoin in vitro study. Drug Dev. Ind. Pharm. 21:1377-1387.
12. Keshary, P. R., and Chien, Y. W. 1984. Mechanism of transdermal controlled nitroglycerin administration. Part 2. Assessment of rate controlling steps. Drug Dev. Ind. Pharm. 10:1663-1699.
13. Kim, M. K., Zhao, H., Lee, C. H., and Kim, D. D. 2001. Formulation of reservoir-type testosterone transdermal delivery system. Int. J. Pharm. 219:51-59.
14. Kirsch, W., Ramesh, K. D., Durshen, U., and Ohnhans, E. E. 1984. Clinical pharmacokinetics of nimodipine in normal and impaired renal function. Int. Clin. Pharmacol. Res. 4:381-389.
15. Krishnaiah, Y. S. R., Satyanarayana, V., and Bhaskar, P. 2003. Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer. Drug Delivery 10:101-109.
16. Krishnaiah, Y. S. R., Satyanarayana, V., and Bhaskar, P. 2002. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int. J. Pharm. 247:19-102.
17. Krishnaiah, Y. S. R., Bhaskar, P., and Satyanarayana, V. 2004. Penetration enhancing effect of ethanol and ethanolic solution of carvone on permeability of nimodipine from HPMC gelsacross the excised rat abdominal skin. Pharm. Dev. Technol. (In press).
18. Krishnaiah, Y. S. R., Satyanarayana, V., and Bhaskar, P. 2002a. Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels. Pharm. Devel. Tech. 7:305-315.
19. Krishnaiah, Y. S. R., Bhaskar, P., and Satyanarayana, V. 2004a. In vitro percutaneous permeability enhancement of nimodipine by limonene across rat abdominal skin. Drug Devel. Ind. Pharmazie. (accepted).
20. Krishnaiah, Y. S. R., Satyanarayana, V., and Karthikeyan R. S. 2002e. Effect of solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharmaceut. Sci. 5:124-131.
21. Kumana, C. R., Kou, M., Yu, M. L., Fung, C. F., and Chang, C. M. 1993. Investigation of nimodipine pharmacokinetics in chinese patients with acute subarachnoid hemorrhage. Eur. J. Clin. Pharmacol. 45:363-368.
22. Moghimi, H., Williams, A., and Barry, B. 1996. A lamellar matrix for stratum corneum intercellular lipids. IV. Effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int. J. Pharm. 145:49-59.
23. Obata, Y., Takayama, K., Machida, Y., and Nagai, T. 1991. Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Des. Del. 8:137-144.
24. Okabe, H., Obata, Y., Takayama, K., and Nagai, T. 1990. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des. Del. 6:229.
25. Pfister, W. R., and Hsieh D. S. 1990. Permeation enhancers compatible with transdermal drug delivery systems. 1. Selection and formulation considerations. Med. Deice Technol. 1:48-55.
26. Williams, A. C., and Barry, B. W. 1992. Skin absorption enhancers. Crit. Rev. Ther. Drug 9:305.
27. Williams, A. C., and Barry, B. W. 1991. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm. Res, 8:17-21.
28. Yammune, M. A., Williams, A. C., and Barry, B. W. 1995. Terpenes penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and mechanism of action. J. Pharm. Pharmacol. 47:978-989.
29. Zhao, K., and Singh, J. 1999, In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J. Control. Rel. 62:359-366.